TickerFacts.

Aclarion, Inc. (ACON): Shareholders' Equity

Annual figures by period end, from SEC filings.

$12.84M
As of 2025-12-31
$17.00M
As of 2026-06-30
+79.3%
3-year compound annual growth
2021-12-31: -$12.83M2022-06-30: $4.24M2022-09-30: $2.93M2022-12-31: $2.23M2023-12-31: -$728.0K2024-12-31: $970.1K2025-12-31: $12.84M$12.84M
2021-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$12.84Mn/m2026-03-18, Balance as of period end
2024-12-31$970.1Kn/m2026-03-18, Balance as of period end
2023-12-31-$728.0Kn/m2025-04-09, Balance as of period end
2022-12-31$2.23Mn/a2024-03-28, Balance as of period end
2022-09-30$2.93Mn/a2023-06-12, Balance as of period end
2022-06-30$4.24Mn/a2023-06-12, Balance as of period end
2021-12-31-$12.83Mn/a2023-06-12, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Aclarion, Inc. (ACON)2025-12-31$12.84Mn/m
Sera Prognostics, Inc. (SERA)2025-12-31$75.41M+57.7%
YD Bio Ltd (YDES)2025-12-31-$2.86Mn/m
BioNexus Gene Lab Corp (BGLC)2025-12-31$8.61M+3.5%
American Shared Hospital Services (AMS)2025-12-31$27.69M-7.8%
CapForce Inc. (CFOR)2025-12-31$31.86M+331.6%
Exagen Inc. (XGN)2025-12-31$17.45M+82.9%
Personalis, Inc. (PSNL)2025-12-31$261.19M+28.7%
Biodesix Inc (BDSX)2025-12-31-$2.46Mn/m

Compare ACON, SERA, YDES, BGLC side by side · Screen every company in Services-Medical Laboratories ↗